Dr. Schmader's primary area of research is herpes zoster and postherpetic neuralgia (PHN) and vaccines in older adults. He conducts pre-clinical, epidemiological and intervention studies of zoster and PHN, particularly with the zoster and influenza vaccines. He is involved with other adult vaccine development in older adults. With colleagues in the Division of Infectious Diseases, Dr. Schmader investigates other infections in older adults.
Another major research focus is adverse drug reactions, medication prescribing and pharmacoepidemiology in the elderly. The objective of the medication work is to reduce adverse drug reactions, improve inappropriate prescribing and determine drug use patterns in the elderly.
Education and Training
- Fellow In Geriatrics, Medicine, Duke University, 1986 - 1988
- Chief Medical Resident, Medicine, University of Wisconsin at Madison, 1983 - 1983
- Medical Resident, Medicine, University of Wisconsin at Madison, 1980 - 1983
- M.D., Wake Forest University, 1980
- Mentoring Intervention Development in Fall and Fracture Prevention
- RSV-E-301 Recombinant F Nanopartical Vaccine Study
- Hartford COE in Geriatric Medicine and Geriatric Psychiatry Sustainability Fund
- VTEU Task Area A, Base Protocol FY.2016.A1.0026
- John A. Hartford Foundation's Centers of Excellence (CoE)
- UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
- Clinical and Molecular Epidemiology of Multidrug-Resistant Organisms in a Community Hospital
- Urinary Dysfunction in the Elderly: Informing Accountable Urologic Care